Collegium Pharmaceutical, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Collegium Pharmaceutical, Inc. (COLL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $77.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-06
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $77.68M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $91.49M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $55.56M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $66.25M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $77.68M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $91.49M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $55.56M 10-K · filed 2026-02-26 |
| 2025-09-30 | $66.25M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $76.71M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $82.41M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $54.16M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $52.29M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $72.23M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $50.04M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $57.29M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $61.07M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $36.24M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $43.10M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $47.10M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $45.95M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $56.39M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $63.92M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $39.17M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $44.90M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $48.71M 10-Q · filed 2020-05-07 |
| 2017-09-30 | $18.89M 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |